InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,534.80
(
0.93%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
69,516.61
(
0.05%
)
Post# of 253509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

HighPeaks

Send PM Follow Ignore
Followers 163
Posts 10161
Boards Moderated 0
Alias Born 08/06/2014

HighPeaks

Re: None

Thursday, 06/09/2022 12:11:23 AM

Thursday, June 09, 2022 12:11:23 AM

Post# of 253509
Have you guys heard about Dostarlimab and the recent results in healing 100% of patients in a small colan cancer trial in Sloan Kettering? What’s your take on $ANAB as it seems they still get 8-25% royalties above 1 billion in sales even though GSK has taken over the development of the drug. I haven’t seen any mention though of the $anab and Dostarlimab connection mentioned recently since Sunday’s trial news. I’m not a biotech investor although I do trade stocks. What’s your take?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up